Partial-Methylated HeyL Promoter Predicts the Severe Illness in Egyptian COVID-19 Patients

BACKGROUND: To date (14 January 2022), the incidence and related mortality rate of COVID-19 in America, Europe, and Asia despite administrated of billions doses of many approved vaccines are still higher than in Egypt. Epigenetic alterations mediate the effects of environmental factors on the regula...

Descripción completa

Detalles Bibliográficos
Autores principales: Fadel, Hewida H., Ahmed, Mohammad Abd EL-Rahman, Gharbeya, Kareem Mahamoud, Mohamed, Mohammed Ahmed Khamis, Roushdy, Mohamed N., Almiry, Reda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9153385/
https://www.ncbi.nlm.nih.gov/pubmed/35655915
http://dx.doi.org/10.1155/2022/6780710

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9153385/
https://www.ncbi.nlm.nih.gov/pubmed/35655915
http://dx.doi.org/10.1155/2022/6780710

Ejemplares similares